Mucosal IgA to pre-fusion F protein predicts protection from RSV infection in a high burden setting
Hodgson, D.; Jarju, S.; Gatcombe, L.; Coleman, T.; Dowgier, G.; Wenlock, R. D.; Lindsey, B. B.; Danso, M.; Barratt, N.; Gomez, M.; Grouneva, I.; Jagne, Y. J.; Kampmann, B.; Wu, M. Y.; Otter, A.; Flasche, S.; Kucharski, A.; de Silva, T. I.
Show abstract
Respiratory syncytial virus (RSV) causes over 100,000 annual deaths, predominantly in low-and middle-income countries, yet immunological correlates of protection remain poorly defined in high-burden settings. We conducted an intensively sampled prospective household cohort study in The Gambia, following 342 participants over 12 months with weekly PCR testing and longitudinal serum and nasal sampling. Using a Bayesian hierarchical framework jointly modelling antibody kinetics, household transmission dynamics, and imperfect PCR ascertainment, we characterised humoral immunity to RSV-A antigens across systemic and mucosal compartments. Mucosal IgA to the pre-fusion F (pre-F) protein was the strongest predictor of protection against infection (AUC = 0.72), outperforming serum anti-Pre-F IgG (AUC = 0.66). Serum and mucosal responses were largely compartment-independent (r = 0.02-0.28), with a combined serum and mucosal anti-Pre-F model outperforming either alone, and both biomarkers correlating with RSV-A neutralising titres. These findings have direct implications for designing RSV infection preventing vaccine strategies.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms 96%
- Typically asymptomatic but with robust antibody formation: Children’s unique humoral immune response to SARS-CoV-2 95%
- Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19 95%
Similar papers in this journal
- Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 94%
- Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study 94%
- Fibroblast growth factor-9 expression in airway epithelial cells amplifies the type I interferon response and alters influenza A virus pathogenesis 94%
Similar papers in this journal
- Serological reconstruction of COVID-19 epidemics through analysis of antibody kinetics to SARS-CoV-2 proteins 95%
- Anti-membrane and anti-spike antibodies are long-lasting and together discriminate between past COVID-19 infection and vaccination 94%
- Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2 94%
Similar papers in this journal
- Leveraging Pre-Vaccination Antibody Titers across Multiple Influenza H3N2 Variants to Forecast the Post-Vaccination Response 95%
- Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling 95%
- Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic 95%
Similar papers in this journal
- The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism 96%
- Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections 95%
- SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.